Cipla set to launch repurposed drug Favipiravir for COVID-19: CSIR
Cipla has scaled up the process in their manufacturing facility and approached Drug Controller General of India (DCGI) for permission ...
Cipla has scaled up the process in their manufacturing facility and approached Drug Controller General of India (DCGI) for permission ...
©Copyright Indus Scrolls. Tech-enabled by Ananthapuri Technologies
©Copyright Indus Scrolls. Tech-enabled by Ananthapuri Technologies